For further processing only. Others UDP-N-Acetylgalactosamine UDP-N-Acetylgalactosamine 78 1403506419168 The sale of the Product does not exhaust or grant any rights in third party patents including patents of companies of the F. Hoffmann - La Roche AG group of companies, in particular, for the use of modified antibodies obtained by using the product. 3.2.17.2.67.0 sodium salt, lyophilizate 06369855103 UDP-N-Acetylgalactosamine, Disodium UDP-N-Acetylgalactosamine Reagents, kits custom fill Not Available CustomBiotech product. Please contact your local representative. Unit of measure is "gram". 91183-98-1 en UDP-N-Acetylgalactosamine is an activated sugar, and can be used for in vitro glycoengineering of glycoproteins, e.g. therapeutic proteins. en UDP-N-Acetylgalactosamine is a disodium salt, provided as a white, lyophilized substance. en Benefits of using in vitro glycoengineering to modify glycosylation of therapeutic proteins: Time- and cost-saving generation of glycan variants to develop improved drugs Optimized glycosylation without compromising other CQAs or product yield Improved lot-to-lot consistency to reduce risk of product quality variation and resulting delays Generation of glycoprofiles which may not otherwise be generated Streamlined analytics in comparability studies en UDP-N-Acetylgalactosamine can be used for glycosylation of target molecules with a suitable enzyme. en Appearance: White powderSolution (c = 100 mg/mL water): Clear, colorlessIdentity (1H-NMR): spectrum conforms to reference spectrum.UDPGalNAc (HPLC), based on dry weight: ≥95%UDPGalNAc (HPLC): ≥97% area%Water (K. Fischer): ≤8%Na (flame photometer): 6.0 - 8.0%UDPGlucNAc (1H-NMR): ≤1%UMP (HPLC): ≤1 area%UDP (HPLC): ≤1 area%Heavy metals (as Pb): ≤25 ppmProteins (Bradford): ≤100 μg/gEndotoxine: ≤0.5 EU/mgBioburden: ≤100 CFU/gStability: At +2 to +8°C within specification range for 36 months. en